NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Collections
Citation
Yoshihama, Sayuri; Roszik, Jason; Downs, Isaac; Meissner, Torsten; Vijayan, Saptha; Chapuy, Bjoern; Sidiq, Tabasum; Shipp, Margaret; Lizee, Gregory; Kobayashi, Koichi (2016). NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proceedings of the National Academy of Sciences of the United States of America. Available electronically from https : / /hdl .handle .net /1969 .1 /183157.